Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.2K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.2K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Seizures: Classification01:13

Seizures: Classification

2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.5K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.2K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroinflammation and Disease: Pathways and Opportunities.

Annual review of pharmacology and toxicology·2025
Same author

Brain-invading monocytes promote seizure-associated cognitive deficits and neurodegeneration.

Neuropharmacology·2025
Same author

Assessment of Developmental Prosopagnosia in an Individual with Tourette Syndrome and Attention Deficit Hyperactivity Disorder: A Case Report.

Brain sciences·2025
Same author

Brain Abscess Causes Brain Damage With Long-Lasting Focal Cerebral Hypoactivity that Correlates With Abscess Size: A Cross-Sectional 18 F-Fluoro-Deoxyglucose Positron Emission Tomography Study.

Neurosurgery·2024
Same author

Fatigue and depression at 8 weeks and 1 year after bacterial brain abscess and their relationship with cognitive status.

Neuropsychological rehabilitation·2024
Same author

Glyceraldehyde metabolism in mouse brain and the entry of blood-borne glyceraldehyde into the brain.

Journal of neurochemistry·2024

Related Experiment Video

Updated: Mar 18, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
09:32

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

Published on: December 18, 2016

13.0K

A New Approach for Epilepsy.

Ray Dingledine, Bjørnar Hassel

    Cerebrum : the Dana Forum on Brain Science
    |July 14, 2016
    PubMed
    Summary

    Researchers found that inhibiting a key metabolic enzyme reduced seizures in mice with epilepsy. This discovery could lead to new treatments for drug-resistant epilepsy, a condition affecting millions globally.

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Epilepsy Research

    Background:

    • Epilepsy affects 65 million people globally, with a significant portion experiencing treatment-resistant seizures.
    • Seizures stem from disrupted communication between nerve cells in the brain.

    Purpose of the Study:

    • To investigate the anti-seizure potential of inhibiting a specific enzyme crucial for metabolic communication.

    Main Methods:

    • The study utilized a mouse model of epilepsy.
    • An enzyme critical in metabolic communication was inhibited.

    Main Results:

    • Inhibition of the target enzyme demonstrated a notable anti-seizure effect in the epileptic mice.
    • This suggests a link between metabolic pathways and seizure activity.

    More Related Videos

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
    07:01

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

    Published on: May 16, 2019

    9.7K
    Performing Behavioral Tasks in Subjects with Intracranial Electrodes
    12:10

    Performing Behavioral Tasks in Subjects with Intracranial Electrodes

    Published on: October 2, 2014

    12.0K

    Related Experiment Videos

    Last Updated: Mar 18, 2026

    Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
    09:32

    Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients

    Published on: December 18, 2016

    13.0K
    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
    07:01

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

    Published on: May 16, 2019

    9.7K
    Performing Behavioral Tasks in Subjects with Intracranial Electrodes
    12:10

    Performing Behavioral Tasks in Subjects with Intracranial Electrodes

    Published on: October 2, 2014

    12.0K

    Conclusions:

    • Targeting this metabolic enzyme may offer a novel therapeutic strategy for epilepsy.
    • Findings could pave the way for new treatments for drug-resistant epilepsy.